Table 2.
Compounds | Cell Lines (IC50 μM) | ||||||
---|---|---|---|---|---|---|---|
MCF-7 | MDA-MB-231 | t-47D | HCT-116 | DLD-1 | K562 | Molt4 | |
1 | – a | – a | – a | – a | – a | 17.60 | 18.06 |
2 | – a | – a | – a | – a | – a | – a | – a |
3 | – a | – a | – a | 13.36 | – a | 7.87 | 14.14 |
4 | – a | – a | – a | – a | – a | – a | – a |
5 | – a | – a | 18.08 | – a | 2.50 | 10.93 | 8.61 |
6 | – a | 5.98 | – a | – a | – a | – a | – a |
7 | 1.03 | – a | 0.65 | 0.78 | 0.55 | 0.01 | 0.02 |
Doxorubicin b | 1.10 | 1.16 | 0.61 | 0.27 | 0.72 | 0.62 | 0.04 |
a IC50 > 20 μM; b positive control.